|
G |
Aaas |
aladin WD repeat nucleoporin |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of AAAS mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 7:143,937,198...143,956,668
Ensembl chr 7:143,937,199...143,956,668
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression increases expression multiple interactions increases activity |
ISO EXP |
2-Acetylaminofluorene results in decreased expression of ABCB1 mRNA 2-Acetylaminofluorene results in increased expression of ABCB1 mRNA; 2-Acetylaminofluorene results in increased expression of ABCB1A mRNA lipopolysaccharide, E coli O55-B5 inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1A mRNA] 2-Acetylaminofluorene results in increased expression of ABCB1 mRNA; 2-Acetylaminofluorene results in increased expression of ABCB1 protein Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA]; Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 protein] 2-Acetylaminofluorene results in increased activity of ABCB1 protein [2-Acetylaminofluorene results in increased activity of AKT1 protein] which results in increased expression of ABCB1 mRNA; [2-Acetylaminofluorene results in increased activity of RAC1 protein] which results in increased expression of ABCB1 mRNA; [RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA] |
CTD |
PMID:11170838 PMID:11960367 PMID:12387747 PMID:17303067 PMID:17669244 PMID:21784091 PMID:22213190 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of ABCB1B mRNA; 2-Acetylaminofluorene results in increased expression of ABCB1B protein [2-Acetylaminofluorene results in increased abundance of Reactive Oxygen Species] which results in increased expression of ABCB1B mRNA; lipopolysaccharide, E coli O55-B5 inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1B mRNA]; RELA protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1B mRNA] |
CTD |
PMID:11020383 PMID:11170838 PMID:12801967 PMID:17070881 PMID:22084566 |
|
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ABCC1 mRNA |
CTD |
PMID:12801967 PMID:17669244 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcc10 |
ATP binding cassette subfamily C member 10 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of ABCC10 mRNA |
CTD |
PMID:12566991 |
|
NCBI chr 9:17,041,351...17,061,263
Ensembl chr 9:17,041,389...17,063,780
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of ABCC2 mRNA 2-Acetylaminofluorene results in increased expression of ABCC2 mRNA; 2-Acetylaminofluorene results in increased expression of ABCC2 protein NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCC2 mRNA] |
CTD |
PMID:10691972 PMID:16381673 PMID:16426233 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of ABCC3 mRNA; 2-Acetylaminofluorene results in increased expression of ABCC3 protein |
CTD |
PMID:10691972 PMID:12801967 |
|
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression increases activity multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of ABCG2 mRNA 2-Acetylaminofluorene results in increased activity of ABCG2 protein 2-Acetylaminofluorene results in increased expression of ABCG2 mRNA; 2-Acetylaminofluorene results in increased expression of ABCG2 protein NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCG2 mRNA] |
CTD |
PMID:12819005 PMID:16381673 PMID:17538966 PMID:17669244 PMID:27475308 |
|
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of ACAA2 mRNA |
CTD |
PMID:14656948 |
|
NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of ACMSD mRNA |
CTD |
PMID:17070881 |
|
NCBI chr13:44,424,689...44,468,734
Ensembl chr13:44,424,689...44,468,734
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ACOT9 mRNA |
CTD |
PMID:21784091 |
|
NCBI chr X:43,543,069...43,592,200
Ensembl chr X:43,543,070...43,592,200
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ACSL3 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of AEN mRNA |
CTD |
PMID:17070881 PMID:21607683 PMID:22584684 |
|
NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Carbon Tetrachloride] affects the expression of AFP protein; [2-Acetylaminofluorene co-treated with Choline deficiency] results in increased expression of AFP protein 2-Acetylaminofluorene results in increased expression of AFP mRNA; 2-Acetylaminofluorene results in increased expression of AFP protein |
CTD |
PMID:6187438 PMID:11350689 PMID:11813887 PMID:15133858 PMID:17538966 |
|
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of AHR mRNA |
CTD |
PMID:25224404 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of AK1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 3:11,652,143...11,659,135
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of AKR1B3 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
multiple interactions increases expression |
EXP ISO |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA 2-Acetylaminofluorene results in increased expression of AKR1B10 mRNA |
CTD |
PMID:14656948 PMID:26198647 |
|
NCBI chr 4:61,813,265...61,830,371
Ensembl chr 4:61,771,970...61,828,657
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of AKR7A3 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein; [2-Acetylaminofluorene results in increased activity of AKT1 protein] which results in increased expression of ABCB1 mRNA 2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein; Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:11960367 PMID:17303067 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alb |
albumin |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Choline deficiency] results in increased expression of ALB protein 2-Acetylaminofluorene results in increased expression of ALB protein |
CTD |
PMID:6187438 PMID:15133858 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:17070881 PMID:22584684 |
|
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882
|
|
G |
Aldh1a7 |
aldehyde dehydrogenase family 1, subfamily A7 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ALDH1A4 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 1:240,584,233...240,601,843
Ensembl chr 1:240,562,423...240,601,744
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ALDH3A1 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; Tocotrienols affects the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein] |
CTD |
PMID:15548946 PMID:15554553 |
|
NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
|
|
G |
Anapc11 |
anaphase promoting complex subunit 11 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of ANAPC11 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr10:109,774,779...109,785,877
Ensembl chr10:109,774,878...109,785,877
|
|
G |
Anxa3 |
annexin A3 |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of ANXA3 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ANXA3 mRNA] [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of ANXA3 mRNA |
CTD |
PMID:17317680 PMID:18071240 |
|
NCBI chr14:14,371,921...14,426,503
Ensembl chr14:14,364,008...14,426,437
|
|
G |
Anxa8 |
annexin A8 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of ANXA8 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr16:10,417,174...10,432,388
Ensembl chr16:10,417,185...10,432,393
|
|
G |
Aox1 |
aldehyde oxidase 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AOX1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AOX1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 9:64,929,682...65,007,872
Ensembl chr 9:64,929,721...65,007,870
|
|
G |
Apoa2 |
apolipoprotein A2 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of APOA2 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr13:89,596,872...89,598,805
Ensembl chr13:89,597,138...89,598,802
|
|
G |
Apoa4 |
apolipoprotein A4 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of APOA4 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of APOC3 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 8:50,529,318...50,531,498
Ensembl chr 8:50,529,318...50,531,498
|
|
G |
Apod |
apolipoprotein D |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of APOD mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301
|
|
G |
Aqp5 |
aquaporin 5 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of AQP5 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr 7:141,249,044...141,252,576
Ensembl chr 7:141,249,044...141,252,578
|
|
G |
Areg |
amphiregulin |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of AREG mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of AREG mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of ASGR1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr10:56,662,188...56,666,086
Ensembl chr10:56,662,242...56,666,086
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ATP6V1D mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of BAX mRNA] 2-Acetylaminofluorene results in increased expression of BAX mRNA [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein] |
CTD |
PMID:11915028 PMID:17070881 PMID:17317680 PMID:19167416 PMID:21607683 PMID:22584684 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein] 2-Acetylaminofluorene results in increased expression of BCL2 mRNA |
CTD |
PMID:11915028 PMID:19167416 PMID:22213190 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
EXP ISO |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein] 2-Acetylaminofluorene results in increased expression of BCL2L1 mRNA |
CTD |
PMID:11915028 PMID:21607683 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of BIRC5 mRNA |
CTD |
PMID:19167416 PMID:22213190 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of BRCA1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP ISO |
2-Acetylaminofluorene results in increased expression of BTG2 mRNA |
CTD |
PMID:17070881 PMID:21607683 |
|
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of BZW1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 9:65,279,675...65,293,471
Ensembl chr 9:65,279,675...65,291,651
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of C4BPA mRNA |
CTD |
PMID:16510358 |
|
NCBI chr13:47,342,090...47,377,580
Ensembl chr13:47,342,079...47,377,703
|
|
G |
C6 |
complement C6 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of C6 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797
|
|
G |
C7 |
complement C7 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of C7 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 2:54,707,621...54,781,624
Ensembl chr 2:54,709,138...54,777,729
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CACNA2D1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr 4:15,706,974...16,130,848
Ensembl chr 4:15,710,417...16,130,848
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CADM1 protein |
CTD |
PMID:17326163 |
|
NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
|
|
G |
Car2 |
carbonic anhydrase 2 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CAR2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CAR2 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
EXP |
2-Acetylaminofluorene inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] results in increased cleavage of CASP3 protein]; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP3 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP3 protein] |
CTD |
PMID:12907702 PMID:23665045 PMID:26364502 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein] |
CTD |
PMID:23665045 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp9 |
caspase 9 |
increases activity increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased activity of CASP9 protein 2-Acetylaminofluorene results in increased expression of CASP9 protein Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP9 protein] |
CTD |
PMID:23665045 PMID:26364502 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
multiple interactions decreases activity decreases expression |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of CAT protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of CAT protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in decreased activity of CAT protein] |
CTD |
PMID:17761372 PMID:23665045 PMID:26364502 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cavin3 |
caveolae associated protein 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CAVIN3 mRNA |
CTD |
PMID:14656948 |
|
NCBI chr 1:170,317,099...170,318,688
Ensembl chr 1:170,317,113...170,318,935
|
|
G |
Cblc |
Cbl proto-oncogene C |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CBLC mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 1:80,699,321...80,716,146
Ensembl chr 1:80,699,323...80,716,146
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of CBR1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
|
|
G |
Cck |
cholecystokinin |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of CCK mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 8:130,120,525...130,127,515
Ensembl chr 8:130,120,523...130,127,392
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
affects expression |
EXP |
2-Acetylaminofluorene affects the expression of CCL2 mRNA; 2-Acetylaminofluorene affects the expression of CCL2 protein |
CTD |
PMID:25051504 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CCL7 protein |
CTD |
PMID:25051504 |
|
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of CCN2 mRNA; 2-Acetylaminofluorene results in increased expression of CCN2 protein Iloprost inhibits the reaction [2-Acetylaminofluorene results in increased expression of CCN2 mRNA] |
CTD |
PMID:15940639 |
|
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of CCNA2 protein |
CTD |
PMID:15158336 |
|
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression increases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of CCNB1 protein 2-Acetylaminofluorene results in increased expression of CCNB1 mRNA |
CTD |
PMID:15158336 PMID:22584684 |
|
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of CCNB2 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CCNB2 mRNA] |
CTD |
PMID:17317680 PMID:19167416 PMID:22584684 |
|
NCBI chr 8:76,847,972...76,861,165
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA] 2-Acetylaminofluorene results in increased expression of CCND1 mRNA |
CTD |
PMID:14633663 PMID:22584684 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions decreases activity |
EXP |
2-Acetylaminofluorene inhibits the reaction [CDK2 protein binds to CCNE1 protein]; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA] 2-Acetylaminofluorene results in decreased activity of CCNE1 protein |
CTD |
PMID:10708481 PMID:14633663 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Ccng1 |
cyclin G1 |
decreases expression increases expression |
EXP ISO |
2-Acetylaminofluorene results in decreased expression of CCNG1 mRNA 2-Acetylaminofluorene results in increased expression of CCNG1 mRNA |
CTD |
PMID:17070881 PMID:17317680 PMID:19167416 PMID:21607683 PMID:22584684 |
|
NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
|
|
G |
Cd276 |
Cd276 molecule |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CD276 mRNA |
CTD |
PMID:17070881 PMID:21784091 |
|
NCBI chr 8:63,312,060...63,350,411
Ensembl chr 8:63,318,019...63,350,269
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
EXP IEP |
2-Acetylaminofluorene results in increased expression of CD44 mRNA 2-Fluorenylacetamide increases CD44 mRNA in liver, and protein in liver and serum |
CTD |
PMID:17187413 PMID:22584684, PMID:31966914 |
RGD:25823185 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cdc37 |
cell division cycle 37, HSP90 cochaperone |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 mRNA; [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 protein |
CTD |
PMID:16317707 |
|
NCBI chr 8:22,160,922...22,173,797
Ensembl chr 8:22,154,067...22,173,804
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDCA3 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 4:157,347,876...157,351,889
Ensembl chr 4:157,348,020...157,351,604
|
|
G |
Cdh13 |
cadherin 13 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDH13 mRNA |
CTD |
PMID:21784091 |
|
NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
|
|
G |
Cdh22 |
cadherin 22 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDH22 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr 3:161,574,993...161,971,102
Ensembl chr 3:161,575,631...161,917,285
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDH3 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDK1 mRNA |
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases activity |
EXP |
2-Acetylaminofluorene inhibits the reaction [CDK2 protein binds to CCNE1 protein]; 2-Acetylaminofluorene results in decreased localization of and results in decreased phosphorylation of and results in decreased activity of CDK2 protein 2-Acetylaminofluorene results in decreased activity of CDK2 protein |
CTD |
PMID:10708481 PMID:15158336 |
|
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases activity |
EXP |
2-Acetylaminofluorene results in increased activity of CDK4 protein |
CTD |
PMID:15158336 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
EXP ISO |
2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of CDKN1A protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA]; pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]] 2-Acetylaminofluorene results in increased expression of CDKN1A mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CDKN1A mRNA] 2-Acetylaminofluorene results in increased expression of CDKN1A mRNA; 2-Acetylaminofluorene results in increased expression of CDKN1A protein |
CTD |
PMID:10708481 PMID:11003613 PMID:14633663 PMID:17070881 PMID:17317680 PMID:17582756 PMID:19167416 PMID:21607683 PMID:22213190 PMID:22584684 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
EXP |
2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]; Pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] |
CTD |
PMID:17582756 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions increases expression increases methylation |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA; [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A protein 2-Acetylaminofluorene results in increased expression of CDKN2A mRNA 2-Acetylaminofluorene results in increased methylation of CDKN2A gene; 2-Acetylaminofluorene results in increased methylation of CDKN2A promoter |
CTD |
PMID:16317707 PMID:18204080 PMID:19167416 PMID:20188851 PMID:22213190 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of CDKN2B mRNA |
CTD |
PMID:17317680 PMID:22213190 |
|
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDKN2C mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 5:129,347,731...129,352,886
Ensembl chr 5:129,347,732...129,352,886
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CDKN3 mRNA |
CTD |
PMID:22213190 PMID:22584684 |
|
NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of CEBPA protein |
CTD |
PMID:20188851 PMID:21785164 |
|
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions decreases expression |
EXP |
2-Acetylaminofluorene inhibits the reaction [CEBPB protein binds to HAMP promoter] 2-Acetylaminofluorene results in decreased expression of CEBPB protein |
CTD |
PMID:21785164 |
|
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
|
|
G |
Ces3a |
carboxylesterase 3a |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of CES3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:37,070,705...37,079,411
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of CKMT1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 3:113,318,559...113,324,459
Ensembl chr 3:113,318,563...113,324,461
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CLDN4 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
|
|
G |
Cldn7 |
claudin 7 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CLDN7 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr10:56,576,326...56,578,632
Ensembl chr10:56,576,428...56,578,626
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CLU mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CLU mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Cmas |
cytidine monophosphate N-acetylneuraminic acid synthetase |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CMAS protein |
CTD |
PMID:6331524 |
|
NCBI chr 4:176,994,129...177,012,445
Ensembl chr 4:176,994,129...177,012,444
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of COL17A1 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 1:267,416,681...267,465,049
Ensembl chr 1:267,417,459...267,463,705
|
|
G |
Commd3 |
COMM domain containing 3 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of COMMD3 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr17:85,356,042...85,359,835
Ensembl chr17:85,356,042...85,359,833
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of COQ6 mRNA |
CTD |
PMID:16158176 |
|
NCBI chr 6:108,076,393...108,087,782
Ensembl chr 6:108,076,306...108,087,696
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of CPQ mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Carbon Tetrachloride] affects the expression of CPS1 protein |
CTD |
PMID:11813887 |
|
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of CREBBP mRNA |
CTD |
PMID:22213190 |
|
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CRYAB mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
|
|
G |
Cryl1 |
crystallin, lambda 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CRYL1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CRYL1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr15:37,543,727...37,663,586
Ensembl chr15:37,543,727...37,663,584
|
|
G |
Csta |
cystatin A |
affects expression |
ISO |
2-Acetylaminofluorene affects the expression of CSTA mRNA |
CTD |
PMID:27825931 |
|
NCBI chr11:67,555,792...67,566,980
Ensembl chr11:67,555,658...67,566,972
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CX3CL1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
affects expression |
EXP |
2-Acetylaminofluorene affects the expression of CXCL1 protein |
CTD |
PMID:25051504 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
affects expression |
EXP |
2-Acetylaminofluorene affects the expression of CXCL10 protein |
CTD |
PMID:25051504 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Carbon Tetrachloride] results in increased expression of CXCL12 protein 2-Acetylaminofluorene results in increased expression of CXCL12 mRNA; 2-Acetylaminofluorene results in increased expression of CXCL12 protein |
CTD |
PMID:12626097 PMID:15579440 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
affects expression |
EXP |
2-Acetylaminofluorene affects the expression of CXCL2 protein |
CTD |
PMID:25051504 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of CXCR4 mRNA [2-Acetylaminofluorene co-treated with Carbon Tetrachloride] results in increased expression of CXCR4 protein |
CTD |
PMID:12626097 PMID:15579440 |
|
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases hydrolysis multiple interactions increases expression |
ISO EXP |
CYP1A1 results in increased hydrolysis of 2-Acetylaminofluorene 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP1A1 mRNA] 2-Acetylaminofluorene analog results in increased expression of CYP1A1 protein; 2-Acetylaminofluorene results in increased expression of CYP1A1 mRNA; 2-Acetylaminofluorene results in increased expression of CYP1A1 protein |
CTD |
PMID:2334931 PMID:10445401 PMID:11888708 PMID:15916741 PMID:20713471 PMID:25224404 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects metabolic processing increases expression decreases expression multiple interactions increases hydrolysis increases activity |
ISO EXP |
CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene 2-Acetylaminofluorene results in increased expression of CYP1A2 protein 2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein; 2-Acetylaminofluorene results in decreased expression of CYP1A2 protein NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] CYP1A2 results in increased hydrolysis of 2-Acetylaminofluorene CYP1A2 protein results in increased activity of 2-Acetylaminofluorene |
CTD |
PMID:2334931 PMID:2655891 PMID:15450435 PMID:15916741 PMID:16381673 PMID:28245158 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:17317680 PMID:20713471 |
|
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of CYP2A22 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 1:83,711,223...83,725,222
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases expression increases expression |
EXP |
2-Acetylaminofluorene analog results in decreased expression of CYP2B1 protein; 2-Acetylaminofluorene results in decreased expression of CYP2B1 protein 2-Acetylaminofluorene results in increased expression of CYP2B1 protein |
CTD |
PMID:10445401 PMID:15916741 |
|
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
decreases expression |
EXP |
2-Acetylaminofluorene analog results in decreased expression of CYP2B2 protein; 2-Acetylaminofluorene results in decreased expression of CYP2B2 protein |
CTD |
PMID:15916741 |
|
NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CYP2C13 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 1:258,796,624...258,877,023
Ensembl chr 1:258,796,622...258,877,045
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CYP2E1 protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP2E1 protein] 2-Acetylaminofluorene analog results in increased expression of CYP2E1 protein; 2-Acetylaminofluorene results in increased expression of CYP2E1 protein |
CTD |
PMID:14656948 PMID:15916741 PMID:16158176 PMID:17393424 PMID:23665045 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CYP3A2 protein |
CTD |
PMID:10445401 |
|
NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA; 2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 protein [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP3A23-3A1 mRNA; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA]; Trabectedin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:12504080 PMID:14656948 PMID:16158176 |
|
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp4f5 |
cytochrome P450, family 4, subfamily f, polypeptide 5 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of CYP4F5 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 7:14,559,806...14,574,345
Ensembl chr 7:14,529,482...14,574,361
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
|
|
G |
Dap |
death-associated protein |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of DAP mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of DAP mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 2:84,275,884...84,328,998
Ensembl chr 2:84,275,884...84,328,998
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of DDAH1 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 2:251,634,368...251,766,009
Ensembl chr 2:251,634,431...251,766,014
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of DDIT4L mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 2:242,882,219...242,885,088
Ensembl chr 2:242,882,306...242,885,131
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of DDR1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr20:3,553,430...3,574,959
Ensembl chr20:3,552,929...3,575,780
|
|
G |
Des |
desmin |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of DES mRNA |
CTD |
PMID:17187413 |
|
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity |
EXP |
2-Acetylaminofluorene results in decreased activity of DHODH protein |
CTD |
PMID:6331524 |
|
NCBI chr19:42,066,103...42,087,906
Ensembl chr19:42,066,351...42,082,012
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of DLK1 mRNA; 2-Acetylaminofluorene results in increased expression of DLK1 protein |
CTD |
PMID:15567716 PMID:17187413 PMID:17538966 |
|
NCBI chr 6:133,576,513...133,583,751
Ensembl chr 6:133,552,821...133,583,751
|
|
G |
Dmp1 |
dentin matrix acidic phosphoprotein 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of DMP1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr14:6,889,851...6,923,961
Ensembl chr14:6,889,856...6,900,733
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression increases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of E2F1 protein 2-Acetylaminofluorene results in increased expression of E2F1 mRNA |
CTD |
PMID:15158336 PMID:19167416 PMID:22213190 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of E2F3 protein |
CTD |
PMID:15158336 PMID:19167416 |
|
NCBI chr17:36,334,136...36,408,831
Ensembl chr17:36,334,147...36,408,831
|
|
G |
E2f4 |
E2F transcription factor 4 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of E2F4 protein |
CTD |
PMID:15158336 |
|
NCBI chr19:37,252,828...37,260,239
Ensembl chr19:37,252,843...37,260,239
|
|
G |
Eda2r |
ectodysplasin A2 receptor |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of EDA2R mRNA |
CTD |
PMID:21607683 |
|
NCBI chr X:66,560,200...66,602,509
Ensembl chr X:66,561,286...66,602,506
|
|
G |
Egf |
epidermal growth factor |
decreases localization multiple interactions |
EXP |
2-Acetylaminofluorene results in decreased localization of EGF protein 2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:10900465 |
|
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions decreases expression |
EXP |
2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein] 2-Acetylaminofluorene results in decreased expression of EGFR mRNA |
CTD |
PMID:10900465 PMID:22213190 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of EGR1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Ei24 |
EI24, autophagy associated transmembrane protein |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of EI24 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 8:39,254,883...39,271,238
Ensembl chr 8:39,254,889...39,266,959
|
|
G |
Emp2 |
epithelial membrane protein 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of EMP2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr10:5,433,248...5,467,840
Ensembl chr10:5,433,248...5,467,839
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of ENC1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
|
|
G |
Eno1 |
enolase 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of ENO1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of ENO1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of EPCAM mRNA |
CTD |
PMID:17070881 PMID:17187413 |
|
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
|
|
G |
Epha1 |
Eph receptor A1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of EPHA1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 4:71,749,100...71,763,681
Ensembl chr 4:71,749,242...71,763,679
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP ISO |
2-Acetylaminofluorene results in increased expression of EPHX1 mRNA |
CTD |
PMID:17070881 PMID:17317680 PMID:21607683 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ERBB2 protein |
CTD |
PMID:11350689 |
|
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of ESR1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Exoc4 |
exocyst complex component 4 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of EXOC4 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 4:60,549,128...61,358,305
Ensembl chr 4:60,549,197...61,355,994
|
|
G |
Fam110a |
family with sequence similarity 110, member A |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of FAM110A mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 3:147,476,580...147,487,170
Ensembl chr 3:147,476,580...147,487,170
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of FAS mRNA |
CTD |
PMID:17070881 PMID:22584684 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fbxw9 |
F-box and WD repeat domain containing 9 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of FBXW9 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr19:26,173,771...26,180,675
Ensembl chr19:26,173,771...26,180,675
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of FHIT mRNA |
CTD |
PMID:17070881 |
|
NCBI chr15:15,697,292...16,862,873
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
affects expression |
EXP |
2-Acetylaminofluorene affects the expression of FLT3 mRNA |
CTD |
PMID:18031378 |
|
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of FN1 mRNA |
CTD |
PMID:15940639 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of FOS protein; Drugs, Chinese Herbal inhibits the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of FOS protein] |
CTD |
PMID:17696247 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Fth1 |
ferritin heavy chain 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of FTH1 protein |
CTD |
PMID:21785164 |
|
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC1 protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC1 protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC1 protein] |
CTD |
PMID:15554553 |
|
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
|
|
G |
Gaa |
alpha glucosidase |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GAA mRNA |
CTD |
PMID:17317680 |
|
NCBI chr10:108,395,873...108,412,999
Ensembl chr10:108,395,860...108,413,059
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of GAS2L3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:29,963,129...29,996,021
Ensembl chr 7:29,959,597...29,986,163
|
|
G |
Gcgr |
glucagon receptor |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCGR mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCGR mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr10:109,707,863...109,716,253
Ensembl chr10:109,707,962...109,716,128
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of GCLC mRNA [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLC mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCLC mRNA |
CTD |
PMID:14656948 PMID:16158176 PMID:16426233 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLM mRNA |
CTD |
PMID:16158176 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GDF15 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of GGT1 mRNA [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GGT1 protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GGT1 protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GGT1 protein] |
CTD |
PMID:15554553 PMID:17187413 |
|
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of GJA1 mRNA; 2-Acetylaminofluorene results in increased expression of GJA1 protein |
CTD |
PMID:15133858 PMID:17187413 |
|
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of GJB1 mRNA |
CTD |
PMID:2559087 |
|
NCBI chr X:71,272,030...71,279,973
Ensembl chr X:71,272,042...71,279,977
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of GJB2 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr15:37,377,313...37,394,494
Ensembl chr15:37,377,316...37,383,277
|
|
G |
Glrx3 |
glutaredoxin 3 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GLRX3 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 1:209,768,696...209,799,912
Ensembl chr 1:209,768,696...209,799,903
|
|
G |
Gpc3 |
glypican 3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of GPC3 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr X:139,579,268...139,947,093
Ensembl chr X:139,579,268...139,916,883
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GPX2 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
increases expression |
EXP ISO |
2-Acetylaminofluorene results in increased expression of GRIA3 mRNA |
CTD |
PMID:17070881 PMID:21607683 |
|
NCBI chr X:127,561,843...127,829,763
Ensembl chr X:127,562,660...127,829,753
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GRINA mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 7:117,304,742...117,307,916
Ensembl chr 7:117,304,742...117,307,916
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity decreases expression |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSR mRNA; Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of GSR protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in decreased activity of GSR protein] |
CTD |
PMID:16158176 PMID:23665045 PMID:26364502 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gss |
glutathione synthetase |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GSS mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of GSTA1 mRNA [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTA2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTA2 mRNA |
CTD |
PMID:14656948 PMID:16158176 PMID:17317680 |
|
NCBI chr 8:85,640,081...85,645,621
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GSTA2 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 9:27,357,490...27,417,023
Ensembl chr 9:27,402,381...27,417,023
|
|
G |
Gsta6 |
glutathione S-transferase alpha 6 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GSTA1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 9:27,475,273...27,533,939
Ensembl chr 9:27,475,273...27,511,176
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of GSTM1 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]; herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]; herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein] 2-Acetylaminofluorene results in increased expression of GSTP1 mRNA; 2-Acetylaminofluorene results in increased expression of GSTP1 protein |
CTD |
PMID:12497209 PMID:12781041 PMID:12907702 PMID:15554553 PMID:17393424 PMID:18271918 PMID:21785164 PMID:22213190 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of GTSE1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 7:126,736,416...126,753,221
Ensembl chr 7:126,736,732...126,753,220
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of H2AX protein |
CTD |
PMID:26338220 |
|
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of HADHA mRNA |
CTD |
PMID:16158176 |
|
NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
multiple interactions decreases expression |
EXP |
2-Acetylaminofluorene inhibits the reaction [CEBPB protein binds to HAMP promoter] 2-Acetylaminofluorene results in decreased expression of HAMP mRNA |
CTD |
PMID:21785164 |
|
NCBI chr 1:89,368,021...89,369,960
Ensembl chr 1:89,368,021...89,369,960
|
|
G |
Hebp2 |
heme binding protein 2 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of HEBP2 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 1:13,713,152...13,719,970
Ensembl chr 1:13,714,440...13,719,829
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of HMGCR mRNA; beta-ionone promotes the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of HMGCR mRNA] |
CTD |
PMID:20435455 |
|
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of HMOX1 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of HRAS protein |
CTD |
PMID:11350689 |
|
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
|
|
G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of HSD17B6 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 7:2,412,370...2,431,249
Ensembl chr 7:2,412,363...2,431,197 Ensembl chr13:2,412,363...2,431,197
|
|
G |
Ica1 |
islet cell autoantigen 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ICA1 mRNA |
CTD |
PMID:21784091 |
|
NCBI chr 4:34,635,509...34,780,187
Ensembl chr 4:34,635,506...34,780,193
|
|
G |
Id1 |
inhibitor of DNA binding 1, HLH protein |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of ID1 mRNA |
CTD |
PMID:15120964 |
|
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
|
|
G |
Ifna1 |
interferon, alpha 1 |
multiple interactions |
EXP |
IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA]; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA]; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA] |
CTD |
PMID:14633663 |
|
NCBI chr 5:106,951,822...106,952,908
Ensembl chr 5:106,952,082...106,952,792
|
|
G |
Ifna2 |
interferon alpha 2 |
multiple interactions |
EXP |
IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein]; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TGFB1 protein]; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD2 protein]; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:11915028 PMID:15368444 |
|
NCBI chr 5:107,416,117...107,416,695
Ensembl chr 5:107,416,117...107,416,695
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] |
CTD |
PMID:14736494 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf2 |
insulin-like growth factor 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of IGF2 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of IGFALS mRNA |
CTD |
PMID:21607683 |
|
NCBI chr10:14,240,308...14,243,554
Ensembl chr10:14,240,219...14,243,597
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
increases activity |
ISO |
2-Acetylaminofluorene results in increased activity of IKBKB protein |
CTD |
PMID:11960367 |
|
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
|
|
G |
Il10 |
interleukin 10 |
affects expression |
EXP |
2-Acetylaminofluorene affects the expression of IL10 protein |
CTD |
PMID:25051504 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il12b |
interleukin 12B |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of IL12B protein |
CTD |
PMID:25051504 |
|
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions affects expression increases expression |
ISO EXP |
2-Acetylaminofluorene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] 2-Acetylaminofluorene affects the expression of IL1B mRNA 2-Acetylaminofluorene results in increased expression of IL1B protein |
CTD |
PMID:14670622 PMID:25051504 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of IL2RA mRNA |
CTD |
PMID:17070881 |
|
NCBI chr17:70,500,672...70,547,929
Ensembl chr17:70,499,083...70,548,071
|
|
G |
Il33 |
interleukin 33 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of IL33 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
|
|
G |
Il5 |
interleukin 5 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of IL5 protein |
CTD |
PMID:25051504 |
|
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
|
|
G |
Il6 |
interleukin 6 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of IL6 protein |
CTD |
PMID:25051504 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Itgb4 |
integrin subunit beta 4 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of ITGB4 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr10:104,524,000...104,560,180
Ensembl chr10:104,523,996...104,561,078
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of JUN protein; Drugs, Chinese Herbal inhibits the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of JUN protein] |
CTD |
PMID:17696247 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kdm6a |
lysine demethylase 6A |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of KDM6A mRNA |
CTD |
PMID:22213190 |
|
NCBI chr X:4,805,493...4,945,788
Ensembl chr X:4,806,277...4,945,944
|
|
G |
Kif11 |
kinesin family member 11 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of KIF11 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 1:256,035,866...256,088,299
Ensembl chr 1:256,035,866...256,088,299
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of KIT protein |
CTD |
PMID:15133858 |
|
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
|
|
G |
Krt15 |
keratin 15 |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of KRT15 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT15 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr10:88,046,803...88,050,622
Ensembl chr10:88,046,803...88,050,622
|
|
G |
Krt19 |
keratin 19 |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of KRT19 mRNA; 2-Acetylaminofluorene results in increased expression of KRT19 protein [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of KRT19 protein |
CTD |
PMID:15133858 PMID:17187413 PMID:17661067 |
|
NCBI chr10:88,055,843...88,060,560
Ensembl chr10:88,055,841...88,060,561
|
|
G |
Krt20 |
keratin 20 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of KRT20 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr10:87,342,514...87,351,045
Ensembl chr10:87,342,619...87,351,045
|
|
G |
Krt23 |
keratin 23 |
multiple interactions increases expression |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT23 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr10:87,391,623...87,407,634
Ensembl chr10:87,391,623...87,407,634
|
|
G |
Krt4 |
keratin 4 |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of KRT4 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT4 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 7:143,517,562...143,523,522
Ensembl chr 7:143,518,010...143,523,503
|
|
G |
Krt8 |
keratin 8 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of KRT8 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of KRT8 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
|
|
G |
Lep |
leptin |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of LEP protein |
CTD |
PMID:25051504 |
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lig4 |
DNA ligase 4 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of LIG4 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr16:85,331,771...85,339,496
Ensembl chr16:85,331,866...85,337,769
|
|
G |
LOC102550598 |
small proline-rich protein 2I-like |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of SPRR2G mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 2:192,520,019...192,521,188
Ensembl chr 2:192,520,733...192,520,960
|
|
G |
Ly6d |
lymphocyte antigen 6 family member D |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of LY6D mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 7:115,993,304...115,994,812
Ensembl chr 7:115,993,301...115,994,783
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of LY6E mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 7:116,355,426...116,359,862
Ensembl chr 7:116,355,698...116,359,862
|
|
G |
Lypd3 |
Ly6/Plaur domain containing 3 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of LYPD3 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 1:81,499,856...81,504,306
Ensembl chr 1:81,499,821...81,504,318
|
|
G |
Lzic |
leucine zipper and CTNNBIP1 domain containing |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of LZIC mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 5:166,430,305...166,443,485
Ensembl chr 5:166,430,400...166,442,284
|
|
G |
Mal |
mal, T-cell differentiation protein |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of MAL mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 3:120,209,647...120,233,655
Ensembl chr 3:120,209,647...120,233,655
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
2-Acetylaminofluorene affects the phosphorylation of and affects the activity of MAPK8 protein |
CTD |
PMID:17546627 |
|
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
affects acetylation decreases expression affects methylation |
EXP |
2-Acetylaminofluorene affects the acetylation of MAT1A exon; 2-Acetylaminofluorene affects the acetylation of MAT1A promoter 2-Acetylaminofluorene results in decreased expression of MAT1A mRNA 2-Acetylaminofluorene affects the methylation of MAT1A exon; 2-Acetylaminofluorene affects the methylation of MAT1A promoter |
CTD |
PMID:22213190 |
|
NCBI chr16:18,690,649...18,709,135
Ensembl chr16:18,690,246...18,709,133
|
|
G |
Matn2 |
matrilin 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MATN2 mRNA; 2-Acetylaminofluorene results in increased expression of MATN2 protein |
CTD |
PMID:17513098 |
|
NCBI chr 7:72,985,832...73,210,093
Ensembl chr 7:72,985,495...73,207,695
|
|
G |
Mbl2 |
mannose binding lectin 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of MBL2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 1:248,435,069...248,442,669
Ensembl chr 1:248,723,397...248,729,962
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions increases expression |
EXP ISO |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of MDM2 protein 2-Acetylaminofluorene results in increased expression of MDM2 mRNA; 2-Acetylaminofluorene results in increased expression of MDM2 protein |
CTD |
PMID:11003613 PMID:19167416 PMID:21607683 PMID:22213190 PMID:22584684 |
|
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression decreases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MGMT mRNA 2-Acetylaminofluorene results in decreased expression of MGMT mRNA |
CTD |
PMID:17070881 PMID:22213190 |
|
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of MGST2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MGST2 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 2:140,708,396...140,727,381
Ensembl chr 2:140,708,397...140,727,281
|
|
G |
Mir106b |
microRNA 106b |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR106B mRNA |
CTD |
PMID:19167416 |
|
NCBI chr12:19,307,752...19,307,833
Ensembl chr12:19,307,752...19,307,833
|
|
G |
Mir125b1 |
microRNA 125b-1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR125B-1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 8:45,798,260...45,798,346
Ensembl chr 8:45,798,260...45,798,346
|
|
G |
Mir130b |
microRNA 130b |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR130B mRNA |
CTD |
PMID:19167416 |
|
NCBI chr11:88,129,773...88,129,854
Ensembl chr11:88,129,773...88,129,854
|
|
G |
Mir132 |
microRNA 132 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR132 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr10:62,014,995...62,015,095
Ensembl chr10:62,014,995...62,015,095
|
|
G |
Mir146b |
microRNA 146b |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR146B mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 1:266,089,488...266,089,575
Ensembl chr 1:266,089,488...266,089,575
|
|
G |
Mir155 |
microRNA 155 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR155 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir17 |
microRNA 17 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR17; 2-Acetylaminofluorene results in increased expression of MIR17 mRNA |
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr15:100,179,879...100,179,962
Ensembl chr15:100,179,879...100,179,962
|
|
G |
Mir181b2 |
microRNA 181b-2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR181B-2 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 3:23,151,455...23,151,542
Ensembl chr 3:23,151,455...23,151,542
|
|
G |
Mir181c |
microRNA 181c |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR181C mRNA |
CTD |
PMID:19167416 |
|
NCBI chr19:25,290,211...25,290,316
Ensembl chr19:25,290,211...25,290,316
|
|
G |
Mir185 |
microRNA 185 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR185 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr11:86,812,702...86,812,781
Ensembl chr11:86,812,702...86,812,781
|
|
G |
Mir18a |
microRNA 18a |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR18A; 2-Acetylaminofluorene results in increased expression of MIR18A mRNA |
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr15:100,180,015...100,180,110
Ensembl chr15:100,180,015...100,180,110
|
|
G |
Mir200a |
microRNA 200a |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR200A mRNA |
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:173,489,366...173,489,454
|
|
G |
Mir200b |
microRNA 200b |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR200B mRNA |
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:173,490,144...173,490,238
Ensembl chr 5:173,490,144...173,490,238
|
|
G |
Mir200c |
microRNA 200c |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR200C mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 4:157,236,786...157,236,854
|
|
G |
Mir202 |
microRNA 202 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR202 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 1:212,295,630...212,295,701
Ensembl chr 1:212,295,630...212,295,701
|
|
G |
Mir204 |
microRNA 204 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR204 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 1:240,403,000...240,403,109
Ensembl chr 1:240,403,000...240,403,109
|
|
G |
Mir205 |
microRNA 205 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR205 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr13:112,233,283...112,233,390
Ensembl chr13:112,233,283...112,233,390
|
|
G |
Mir20a |
microRNA 20a |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR20A; 2-Acetylaminofluorene results in increased expression of MIR20A mRNA |
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr15:100,180,334...100,180,418
Ensembl chr15:100,180,334...100,180,418
|
|
G |
Mir21 |
microRNA 21 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR21 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mir22 |
microRNA 22 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR22 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr10:62,299,592...62,299,686
Ensembl chr10:62,299,592...62,299,686
|
|
G |
Mir221 |
microRNA 221 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR221 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr X:3,684,480...3,684,588
Ensembl chr X:3,684,480...3,684,588
|
|
G |
Mir31 |
microRNA 31 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR31; 2-Acetylaminofluorene results in increased expression of MIR31 mRNA |
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr 5:107,206,515...107,206,620
|
|
G |
Mir34a |
microRNA 34a |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR34A mRNA |
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:167,092,491...167,092,592
Ensembl chr 5:167,092,491...167,092,592
|
|
G |
Mir3545 |
microRNA 3545 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR203 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 6:136,704,947...136,705,061
Ensembl chr 6:136,704,947...136,705,061
|
|
G |
Mir410 |
microRNA 410 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR410 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 6:133,893,997...133,894,072
Ensembl chr 6:133,893,993...133,894,073
|
|
G |
Mir429 |
microRNA 429 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR429 mRNA |
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:173,488,331...173,488,415
Ensembl chr 5:173,488,331...173,488,415
|
|
G |
Mir490 |
microRNA 490 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR490 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 4:63,342,943...63,343,026
Ensembl chr 4:63,342,943...63,343,026
|
|
G |
Mir93 |
microRNA 93 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR93; 2-Acetylaminofluorene results in increased expression of MIR93 mRNA |
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr12:19,307,543...19,307,629
Ensembl chr12:19,307,543...19,307,629
|
|
G |
Mir96 |
microRNA 96 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIR96 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 4:57,463,366...57,463,471
Ensembl chr 4:57,463,366...57,463,471
|
|
G |
Mir99a |
microRNA 99a |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of MIR99A mRNA |
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr11:16,052,153...16,052,233
Ensembl chr11:16,052,153...16,052,233
|
|
G |
Mirlet7b |
microRNA let-7b |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIRLET7B mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 7:126,590,627...126,590,711
Ensembl chr 7:126,590,627...126,590,711
|
|
G |
Mirlet7c1 |
microRNA let-7c-1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIRLET7C-1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr11:16,052,873...16,052,966
Ensembl chr11:16,052,868...16,052,975
|
|
G |
Mirlet7i |
microRNA let-7i |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MIRLET7I mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 7:66,802,731...66,802,815
Ensembl chr 7:66,802,732...66,802,821
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions increases expression |
EXP ISO |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]; Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] 2-Acetylaminofluorene results in increased expression of MKI67 mRNA |
CTD |
PMID:15565650 PMID:17317680 PMID:17393424 PMID:23665045 PMID:26338220 |
|
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MMP2 mRNA |
CTD |
PMID:18678246 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MMP9 mRNA |
CTD |
PMID:18678246 |
|
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
EXP |
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MT1A protein] |
CTD |
PMID:15565650 |
|
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
decreases expression decreases methylation |
EXP |
2-Acetylaminofluorene results in decreased expression of MTHFR mRNA 2-Acetylaminofluorene results in decreased methylation of MTHFR promoter |
CTD |
PMID:22213190 |
|
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Muc1 |
mucin 1, cell surface associated |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of MUC1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of MYBL1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 5:9,279,756...9,315,112
Ensembl chr 5:9,279,970...9,315,114
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions increases mutagenesis increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of MYC protein; Drugs, Chinese Herbal inhibits the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of MYC protein] 2-Acetylaminofluorene results in increased mutagenesis of MYC gene 2-Acetylaminofluorene results in increased expression of MYC protein |
CTD |
PMID:11350689 PMID:17696247 PMID:19167416 PMID:20188851 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of NAMPT mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 6:52,122,085...52,156,473
Ensembl chr 6:52,122,085...52,156,472
|
|
G |
Nat1 |
N-acetyltransferase 1 |
increases activity |
ISO |
NAT1 protein results in increased activity of 2-Acetylaminofluorene |
CTD |
PMID:15450435 |
|
NCBI chr16:23,970,742...23,991,573
Ensembl chr16:23,970,743...23,991,573
|
|
G |
Nat2 |
N-acetyltransferase 2 |
increases activity |
ISO |
NAT2 protein results in increased activity of 2-Acetylaminofluorene |
CTD |
PMID:15450435 |
|
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
|
|
G |
Nek6 |
NIMA-related kinase 6 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of NEK6 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 3:22,811,927...22,888,598
Ensembl chr 3:22,811,927...22,888,598
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
increases expression increases activity |
ISO |
2-Acetylaminofluorene results in increased expression of NFE2L2 mRNA 2-Acetylaminofluorene results in increased activity of NFE2L2 protein |
CTD |
PMID:21607683 PMID:30114225 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases localization |
ISO |
[RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA] 2-Acetylaminofluorene results in increased localization of NFKB1 protein Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased localization of NFKB1 protein] |
CTD |
PMID:11960367 PMID:17303067 |
|
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein; Acetylcysteine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein]; S-Adenosylmethionine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:18404532 |
|
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions increases degradation |
EXP |
[2-Acetylaminofluorene results in increased abundance of Reactive Oxygen Species] which results in increased degradation of NFKBIB protein 2-Acetylaminofluorene results in increased degradation of NFKBIB protein |
CTD |
PMID:11020383 |
|
NCBI chr 1:86,941,073...86,948,845
Ensembl chr 1:86,941,074...86,948,845
|
|
G |
Ngfr |
nerve growth factor receptor |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of TNFRSF10B mRNA |
CTD |
PMID:21607683 |
|
NCBI chr10:83,389,828...83,408,061
Ensembl chr10:83,389,847...83,408,061
|
|
G |
Ninj1 |
ninjurin 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of NINJ1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NINJ1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr17:15,866,235...15,881,284
Ensembl chr17:15,866,237...15,881,327
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of NOS2 protein] |
CTD |
PMID:23665045 PMID:26364502 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of NOS3 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of NOS3 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Notch1 |
notch receptor 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of NOTCH1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
|
|
G |
Nprl2 |
NPR2-like, GATOR1 complex subunit |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of NPRL2 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 8:116,297,950...116,301,123
Ensembl chr 8:116,297,950...116,301,122
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of NQO1 mRNA |
CTD |
PMID:21607683 PMID:22213190 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of NR1I2 mRNA NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA] NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCC2 mRNA]; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCG2 mRNA]; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA]; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP3A11 mRNA] |
CTD |
PMID:12504080 PMID:16381673 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Nudcd2 |
NudC domain containing 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of NUDCD2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr10:25,890,943...25,896,432
Ensembl chr10:25,890,943...25,896,432
|
|
G |
Nudt7 |
nudix hydrolase 7 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of NUDT7 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr19:46,455,745...46,470,070
Ensembl chr19:46,455,761...46,482,050
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of NUPR1 mRNA |
CTD |
PMID:17070881 PMID:22584684 |
|
NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
|
|
G |
Nusap1 |
nucleolar and spindle associated protein 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of NUSAP1 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 3:111,422,267...111,452,600
Ensembl chr 3:111,422,267...111,452,971
|
|
G |
Ociad2 |
OCIA domain containing 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of OCIAD2 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr14:37,432,999...37,449,425
Ensembl chr14:37,435,654...37,444,775
|
|
G |
Olfm1 |
olfactomedin 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of OLFM1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:6,761,031...6,798,739
Ensembl chr 3:6,773,813...6,798,737
|
|
G |
Olr37 |
olfactory receptor 37 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of OLR37 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 1:164,755,094...164,756,059
|
|
G |
Osm |
oncostatin M |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of OSM mRNA |
CTD |
PMID:15743783 PMID:18678246 |
|
NCBI chr14:84,457,487...84,469,426
Ensembl chr14:84,465,515...84,470,409
|
|
G |
Osmr |
oncostatin M receptor |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of OSMR mRNA |
CTD |
PMID:15743783 |
|
NCBI chr 2:56,107,491...56,163,522
Ensembl chr 2:56,110,777...56,151,531
|
|
G |
Padi2 |
peptidyl arginine deiminase 2 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PADI2 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 5:159,428,479...159,471,113
Ensembl chr 5:159,428,515...159,471,144
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of PCK1 mRNA |
CTD |
PMID:16510358 |
|
NCBI chr 3:171,213,936...171,219,885
Ensembl chr 3:171,213,936...171,219,871
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions increases expression |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein] |
CTD |
PMID:16352317 PMID:17393424 PMID:19167416 PMID:23665045 PMID:26364502 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PDIA3 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PDIA3 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 3:113,376,983...113,400,707
Ensembl chr 3:113,376,983...113,400,707
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PECAM1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr10:94,850,971...94,913,202
|
|
G |
Perp |
p53 apoptosis effector related to PMP22 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PERP mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 1:14,224,392...14,236,838
Ensembl chr 1:14,224,393...14,236,846
|
|
G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of PHLDA3 mRNA |
CTD |
PMID:17070881 PMID:21607683 PMID:22584684 |
|
NCBI chr13:52,588,917...52,592,002
Ensembl chr13:52,588,917...52,592,001
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of PHYH mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of PHYH mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr17:77,287,580...77,304,482
Ensembl chr17:77,287,188...77,304,530
|
|
G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
increases mutagenesis |
EXP |
2-Acetylaminofluorene results in increased mutagenesis of PIGA |
CTD |
PMID:22923490 |
|
NCBI chr X:31,786,823...31,799,751
Ensembl chr X:31,786,194...31,799,560
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of PKD1 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr10:13,914,057...13,962,008
Ensembl chr10:13,915,214...13,962,008
|
|
G |
Pkm |
pyruvate kinase M1/2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PKM mRNA; 2-Acetylaminofluorene results in increased expression of PKM protein |
CTD |
PMID:17538966 |
|
NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
|
|
G |
Pkp1 |
plakophilin 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of PKP1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr13:52,705,174...52,753,089
Ensembl chr13:52,705,174...52,752,997
|
|
G |
Plk2 |
polo-like kinase 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of PLK2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of PMAIP1 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PMAIP1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PMAIP1 mRNA] |
CTD |
PMID:17317680 PMID:19167416 |
|
NCBI chr18:62,159,128...62,179,635
Ensembl chr18:62,174,670...62,181,102
|
|
G |
Polk |
DNA polymerase kappa |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of POLK mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 2:27,305,718...27,364,906
Ensembl chr 2:27,305,728...27,364,906
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of POR mRNA |
CTD |
PMID:15089088 |
|
NCBI chr12:23,998,411...24,017,063
Ensembl chr12:23,998,411...24,046,814
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PRC1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr 1:142,087,181...142,108,746
Ensembl chr 1:142,087,208...142,108,746
|
|
G |
Prkch |
protein kinase C, eta |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PRKCH mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PRKCH mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 6:96,479,243...96,677,368
Ensembl chr 6:96,479,430...96,676,225
|
|
G |
Prom1 |
prominin 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PROM1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr14:71,532,321...71,637,400
Ensembl chr14:71,533,063...71,637,417
|
|
G |
Prox1 |
prospero homeobox 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of PROX1 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr13:108,382,536...108,444,107
Ensembl chr13:108,382,399...108,443,294
|
|
G |
Psmd10 |
proteasome 26S subunit, non-ATPase 10 |
increases expression multiple interactions |
EXP |
2-Acetylaminofluorene results in increased expression of PSMD10 protein RB1 protein affects the reaction [2-Acetylaminofluorene results in increased expression of PSMD10 protein] |
CTD |
PMID:16448463 |
|
NCBI chr X:112,323,188...112,328,642
Ensembl chr X:112,323,187...112,328,642
|
|
G |
Psrc1 |
proline and serine rich coiled-coil 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of PSRC1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 2:211,176,437...211,181,078
Ensembl chr 2:211,176,556...211,181,123
|
|
G |
Pten |
phosphatase and tensin homolog |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of PTEN protein |
CTD |
PMID:19167416 |
|
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PTGR1 mRNA |
CTD |
PMID:16158176 |
|
NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of PTGS2 protein] |
CTD |
PMID:23665045 PMID:26364502 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptn |
pleiotrophin |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PTN mRNA |
CTD |
PMID:12057922 |
|
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
|
|
G |
Ptp4a3 |
protein tyrosine phosphatase 4A3 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of PTP4A3 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 7:114,969,699...115,002,902
Ensembl chr 7:114,997,103...115,002,902
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PTPRC mRNA |
CTD |
PMID:17187413 |
|
NCBI chr13:55,061,561...55,174,150
Ensembl chr13:55,061,562...55,173,692
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of PTTG1 mRNA |
CTD |
PMID:19167416 |
|
NCBI chr10:29,014,332...29,026,088
Ensembl chr10:29,020,049...29,026,002
|
|
G |
Pvt1 |
Pvt1 oncogene |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of PVT1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 7:102,648,394...102,871,316
|
|
G |
Rac1 |
Rac family small GTPase 1 |
increases activity multiple interactions |
ISO |
2-Acetylaminofluorene results in increased activity of RAC1 protein [2-Acetylaminofluorene results in increased activity of RAC1 protein] which results in increased expression of ABCB1 mRNA |
CTD |
PMID:11960367 |
|
NCBI chr12:13,090,316...13,111,841
Ensembl chr12:13,090,172...13,111,873
|
|
G |
Rassf1 |
Ras association domain family member 1 |
increases methylation |
EXP |
2-Acetylaminofluorene results in increased methylation of RASSF1 promoter |
CTD |
PMID:20188851 |
|
NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
affects phosphorylation multiple interactions |
EXP |
2-Acetylaminofluorene affects the phosphorylation of RB1 protein 2-Acetylaminofluorene results in increased expression of and results in increased phosphorylation of RB1 protein; RB1 protein affects the reaction [2-Acetylaminofluorene results in increased expression of PSMD10 protein] |
CTD |
PMID:15158336 PMID:16448463 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rbx1 |
ring-box 1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RBX1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 7:122,700,849...122,710,907
Ensembl chr 7:122,700,854...122,709,935
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases activity increases expression multiple interactions increases localization |
ISO EXP |
2-Acetylaminofluorene results in increased activity of RELA protein 2-Acetylaminofluorene results in increased expression of RELA protein geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of RELA protein]; RELA protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1B mRNA] 2-Acetylaminofluorene results in increased localization of RELA protein [RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA] 2-Acetylaminofluorene inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]; Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased localization of RELA protein] |
CTD |
PMID:11020383 PMID:11960367 PMID:14670622 PMID:17303067 PMID:26364502 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rgn |
regucalcin |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of RGN mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of RGN mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr X:1,833,484...1,848,904
Ensembl chr X:1,833,492...1,848,904
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of RGS2 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr13:60,846,458...60,849,061
Ensembl chr13:60,846,308...60,849,094
|
|
G |
Rhbdf2 |
rhomboid 5 homolog 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RHBDF2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr10:105,573,759...105,600,885
Ensembl chr10:105,573,752...105,600,913
|
|
G |
Rhob |
ras homolog family member B |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of RHOB mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 6:33,689,127...33,691,301
Ensembl chr 6:33,689,127...33,691,301
|
|
G |
Rhobtb2 |
Rho-related BTB domain containing 2 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of RHOBTB2 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr15:51,465,148...51,485,562
Ensembl chr15:51,465,148...51,485,692
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of RIPK1 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr17:31,537,580...31,569,904
Ensembl chr17:31,537,591...31,569,904
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RIPK3 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr15:34,470,796...34,479,741
Ensembl chr15:34,470,796...34,479,741
|
|
G |
Ripk4 |
receptor-interacting serine-threonine kinase 4 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RIPK4 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr11:38,251,991...38,274,234
Ensembl chr11:38,251,955...38,274,217
|
|
G |
Ros1 |
ROS proto-oncogene 1 , receptor tyrosine kinase |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ROS1 mRNA |
CTD |
PMID:17187413 |
|
NCBI chr20:33,100,190...33,323,544
Ensembl chr20:33,100,191...33,323,367
|
|
G |
Rplp0 |
ribosomal protein lateral stalk subunit P0 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of RPLP0 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of RPLP0 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr12:46,791,528...46,794,797
Ensembl chr12:46,791,528...46,794,797
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
multiple interactions increases expression decreases expression |
ISO EXP |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of RPRM mRNA] 2-Acetylaminofluorene results in increased expression of RPRM mRNA 2-Acetylaminofluorene results in decreased expression of RPRM mRNA |
CTD |
PMID:17317680 PMID:19167416 PMID:22584684 |
|
NCBI chr 3:39,595,301...39,596,718
Ensembl chr 3:39,595,301...39,596,718
|
|
G |
Rps27l |
ribosomal protein S27-like |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RPS27L mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 8:72,741,155...72,746,090
Ensembl chr 8:72,741,155...72,746,090
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RRM1 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 1:167,538,387...167,562,688
Ensembl chr 1:167,538,263...167,562,688
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of RRM2B mRNA |
CTD |
PMID:21704725 |
|
NCBI chr 7:76,750,045...76,780,817
Ensembl chr 7:76,750,050...76,780,817
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of RSAD2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:45,655,947...45,669,083
Ensembl chr 6:45,655,954...45,669,148
|
|
G |
S100a11 |
S100 calcium binding protein A11 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of S100A11 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 2:193,863,185...193,868,646
Ensembl chr 2:193,866,951...193,868,502
|
|
G |
S100a14 |
S100 calcium binding protein A14 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of S100A14 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 2:189,913,433...189,919,947
|
|
G |
Scarb2 |
scavenger receptor class B, member 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of SCARB2 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr14:17,064,173...17,115,620
Ensembl chr14:17,064,353...17,115,963
|
|
G |
Scpep1 |
serine carboxypeptidase 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SCPEP1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SCPEP1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr10:76,230,371...76,263,866
Ensembl chr10:76,230,373...76,263,866
|
|
G |
Sctr |
secretin receptor |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SCTR mRNA |
CTD |
PMID:17187413 |
|
NCBI chr13:36,039,241...36,090,515
Ensembl chr13:36,039,283...36,090,530
|
|
G |
Serpina7 |
serpin family A member 7 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SERPINA7 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr X:110,226,565...110,232,202
Ensembl chr X:110,226,572...110,232,179
|
|
G |
Serpinb5 |
serpin family B member 5 |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of SERPINB5 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of SERPINB5 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr13:26,903,052...26,923,250
Ensembl chr13:26,903,052...26,923,250
|
|
G |
Serpinf1 |
serpin family F member 1 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of SERPINF1 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
|
|
G |
Sesn2 |
sestrin 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of SESN2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 5:150,684,891...150,703,846
Ensembl chr 5:150,684,133...150,704,117
|
|
G |
Sfn |
stratifin |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SFN mRNA |
CTD |
PMID:19167416 PMID:22213190 |
|
NCBI chr 5:151,823,422...151,824,937
Ensembl chr 5:151,823,887...151,824,633
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SIRT1 protein |
CTD |
PMID:19167416 |
|
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Slc15a5 |
solute carrier family 15, member 5 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of SLC15A5 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 4:171,970,620...172,063,391
Ensembl chr 4:171,970,620...172,063,391
|
|
G |
Slc16a10 |
solute carrier family 16 member 10 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of SLC16A10 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr20:45,138,433...45,260,155
Ensembl chr20:45,143,453...45,260,119
|
|
G |
Slc25a4 |
solute carrier family 25 member 4 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of SLC25A4 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr16:49,266,903...49,270,698
Ensembl chr16:49,266,903...49,270,698
|
|
G |
Slc2a8 |
solute carrier family 2 member 8 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SLC2A8 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 3:12,020,227...12,029,920
Ensembl chr 3:12,020,229...12,029,877
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SLC40A1 mRNA |
CTD |
PMID:21785164 |
|
NCBI chr 9:52,819,451...52,830,461
Ensembl chr 9:52,894,365...52,912,293
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SLCO1A4 mRNA |
CTD |
PMID:16158176 |
|
NCBI chr 4:175,969,549...176,026,227
Ensembl chr 4:175,969,549...176,026,163
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SLCO1B2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of SLCO1B2 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD2 protein; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:15368444 |
|
NCBI chr18:72,550,107...72,612,078
Ensembl chr18:72,550,219...72,612,078
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD3 protein; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:15368444 |
|
NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
|
|
G |
Smad4 |
SMAD family member 4 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of SMAD4 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
|
|
G |
Smo |
smoothened, frizzled class receptor |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SMO mRNA |
CTD |
PMID:17187413 |
|
NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
|
|
G |
Sncg |
synuclein, gamma |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SNCG mRNA |
CTD |
PMID:22213190 |
|
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
|
|
G |
Sntg2 |
syntrophin, gamma 2 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of SNTG2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 6:49,123,084...49,324,530
Ensembl chr 6:49,123,084...49,324,450
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SOCS1 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of SOD1 protein |
CTD |
PMID:17761372 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein; O-(Chloroacetylcarbamoyl)fumagillol inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein] |
CTD |
PMID:17761372 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SOX4 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr17:37,615,022...37,619,728
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of SPINK1 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
|
|
G |
Sprr1a |
small proline-rich protein 1A |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of SPRR1A mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 2:192,669,143...192,671,059
Ensembl chr 2:192,669,143...192,671,059
|
|
G |
Sprr2f |
small proline rich protein 2F |
increases expression multiple interactions |
ISO |
2-Acetylaminofluorene results in increased expression of SPRR2F mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SPRR2F mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 2:192,604,978...192,605,208
|
|
G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of SPTLC2 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 6:111,334,408...111,417,960
Ensembl chr 6:111,339,136...111,417,954
|
|
G |
Sst |
somatostatin |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of SST protein |
CTD |
PMID:16534498 |
|
NCBI chr11:80,358,172...80,359,449
Ensembl chr11:80,358,211...80,359,444
|
|
G |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of ST3GAL3 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 5:136,765,309...136,965,642
Ensembl chr 5:136,766,208...136,965,191
|
|
G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of ST3GAL5 protein |
CTD |
PMID:6331524 |
|
NCBI chr 4:99,937,499...99,999,905
Ensembl chr 4:99,937,558...99,999,902
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of STAT3 protein; Dexamethasone inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of STAT3 protein] |
CTD |
PMID:12957465 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Steap3 |
STEAP3 metalloreductase |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of STEAP3 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr13:36,257,220...36,274,144
Ensembl chr13:36,257,112...36,290,531
|
|
G |
Stmn1 |
stathmin 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of STMN1 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
|
|
G |
Sugct |
succinylCoA:glutarate-CoA transferase |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of SUGCT mRNA |
CTD |
PMID:17070881 |
|
NCBI chr17:49,991,314...51,030,950
|
|
G |
Sulf2 |
sulfatase 2 |
increases expression |
EXP ISO |
2-Acetylaminofluorene results in increased expression of SULF2 mRNA |
CTD |
PMID:17070881 PMID:21607683 |
|
NCBI chr 3:162,791,349...162,872,984
Ensembl chr 3:162,791,355...162,872,831
|
|
G |
Sult1c2a |
sulfotransferase family, cytosolic, 1C, member 2a |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of SULT1C2 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 9:4,152,588...4,168,355
Ensembl chr 9:4,152,589...4,168,221
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SULT1E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of SULT1E1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr14:22,070,861...22,089,264
Ensembl chr14:22,072,024...22,089,248
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of SULT2A1 mRNA |
CTD |
PMID:17070881 |
|
NCBI chr 1:76,558,721...76,614,315
Ensembl chr 1:76,252,329...76,780,230
|
|
G |
Taldo1 |
transaldolase 1 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TALDO1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TALDO1 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 1:214,375,555...214,385,886
Ensembl chr 1:214,375,515...214,385,885
|
|
G |
Tceal9 |
transcription elongation factor A like 9 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TCEAL9 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TCEAL9 mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr X:106,791,333...106,794,667
Ensembl chr X:106,791,333...106,794,657
|
|
G |
Tes |
testin LIM domain protein |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TES mRNA |
CTD |
PMID:21784091 |
|
NCBI chr 4:44,321,883...44,360,407
Ensembl chr 4:44,321,883...44,360,405
|
|
G |
Tf |
transferrin |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of TF mRNA |
CTD |
PMID:16510358 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TFF1 mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
|
|
G |
Tff3 |
trefoil factor 3 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TFF3 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr20:9,850,800...9,855,481
Ensembl chr20:9,850,803...9,855,481
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TFRC mRNA |
CTD |
PMID:21785164 |
|
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TGFB1 protein; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TGFB1 protein] 2-Acetylaminofluorene results in increased expression of TGFB1 mRNA |
CTD |
PMID:15368444 PMID:15940639 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Thrb |
thyroid hormone receptor beta |
increases activity |
ISO |
2-Acetylaminofluorene results in increased activity of THRB protein |
CTD |
PMID:31077750 |
|
NCBI chr15:8,890,578...9,239,815
Ensembl chr15:8,890,578...9,086,282
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of THY1 protein |
CTD |
PMID:17576600 |
|
NCBI chr 8:48,382,121...48,387,271
Ensembl chr 8:48,382,121...48,386,935
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TIMP1 mRNA |
CTD |
PMID:18678246 |
|
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Tkt |
transketolase |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TKT mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TKT mRNA |
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr16:6,609,670...6,634,608
Ensembl chr16:6,609,668...6,634,595
|
|
G |
Tmem134 |
transmembrane protein 134 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of TMEM134 mRNA |
CTD |
PMID:17317680 |
|
NCBI chr 1:219,374,005...219,383,365
Ensembl chr 1:219,374,060...219,379,557
|
|
G |
Tmem184c |
transmembrane protein 184C |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TMEM184C mRNA |
CTD |
PMID:21784091 |
|
NCBI chr19:34,041,128...34,057,165
Ensembl chr19:34,041,219...34,057,159
|
|
G |
Tmem43 |
transmembrane protein 43 |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of TMEM43 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr 4:123,118,468...123,133,610
Ensembl chr 4:123,118,468...123,133,609
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TNF protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of TNF protein] |
CTD |
PMID:18271918 PMID:23665045 PMID:25051504 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
|
|
G |
Top2a |
DNA topoisomerase II alpha |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TOP2A mRNA |
CTD |
PMID:22584684 |
|
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
|
|
G |
Tp53 |
tumor protein p53 |
increases expression decreases expression increases response to substance multiple interactions |
EXP ISO |
2-Acetylaminofluorene results in increased expression of TP53 protein 2-Acetylaminofluorene results in increased expression of TRP53 protein 2-Acetylaminofluorene results in decreased expression of TP53 protein TRP53 protein modified form results in increased susceptibility to 2-Acetylaminofluorene TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of BAX mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CCNB2 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CDKN1A mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of EI24 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PERP mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PMAIP1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of RPRM mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of SERPINB5 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of ZMAT3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of CYP4F15 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of MEG3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of SLC25A4 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of TTR mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ALDH3A1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ANXA3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of AREG mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of COL17A1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of HEBP2 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT15 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT23 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT4 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of LYPD3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of NOS3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PADI2 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PMAIP1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SLC2A8 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SPRR2F mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TFF1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TSHB mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TUBA1C mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of UBE2C mRNA] [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of TP53 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of TP53 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein]; Vanadium promotes the reaction [2-Acetylaminofluorene results in increased expression of TP53 protein] |
CTD |
PMID:7728945 PMID:9667752 PMID:10708481 PMID:11003613 PMID:11915028 PMID:12888115 PMID:14633663 PMID:15565650 PMID:17317680 PMID:19167416 PMID:23665045 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
multiple interactions increases expression |
EXP ISO |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of TRP53INP1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of TRP53INP1 mRNA 2-Acetylaminofluorene results in increased expression of TP53INP1 mRNA 2-Acetylaminofluorene results in increased expression of TRP53INP1 mRNA |
CTD |
PMID:14656948 PMID:16158176 PMID:21607683 PMID:22584684 |
|
NCBI chr 5:24,402,895...24,419,651
Ensembl chr 5:24,410,863...24,416,888
|
|
G |
Tp73 |
tumor protein p73 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of TP73 mRNA |
CTD |
PMID:22213190 |
|
NCBI chr 5:171,355,876...171,415,354
Ensembl chr 5:171,355,876...171,415,354
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions |
EXP |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TRPM2 mRNA |
CTD |
PMID:16158176 |
|
NCBI chr20:11,434,062...11,482,880
Ensembl chr20:11,436,267...11,482,051
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of TSC22D1 mRNA |
CTD |
PMID:15089088 |
|
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TSHB mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 2:205,207,799...205,215,199
Ensembl chr 2:205,207,799...205,212,681
|
|
G |
Ttr |
transthyretin |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of TTR mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr18:15,532,963...15,542,180
Ensembl chr18:15,532,963...15,540,177
|
|
G |
Tuba1c |
tubulin, alpha 1C |
multiple interactions |
ISO |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TUBA1C mRNA] |
CTD |
PMID:17317680 |
|
NCBI chr 7:140,716,113...140,723,717
Ensembl chr 7:140,716,113...140,723,714
|
|
G |
Tubb4b |
tubulin, beta 4B class IVb |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of TUBB4B mRNA |
CTD |
PMID:21607683 PMID:22584684 |
|
NCBI chr 3:2,441,585...2,444,369
Ensembl chr 3:2,441,733...2,444,281
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of TUBB5 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr20:3,422,448...3,426,420
Ensembl chr20:3,422,461...3,426,371
|
|
G |
Tubb6 |
tubulin, beta 6 class V |
increases expression |
ISO |
2-Acetylaminofluorene results in increased expression of TUBB6 mRNA |
CTD |
PMID:21607683 |
|
NCBI chr18:63,130,542...63,140,181
Ensembl chr18:63,130,542...63,140,181
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
increases expression multiple interactions |
ISO EXP |
2-Acetylaminofluorene results in increased expression of UBE2C mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of UBE2C mRNA] |
CTD |
PMID:17317680 PMID:22584684 |
|
NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of 2-Acetylaminofluorene analog |
CTD |
PMID:11375903 |
|
NCBI chr 9:95,161,157...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
increases expression |
ISO EXP |
2-Acetylaminofluorene results in increased expression of VCAM1 mRNA 2-Acetylaminofluorene results in increased expression of VCAM1 protein |
CTD |
PMID:21607683 PMID:25051504 |
|
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions increases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of VEGFA mRNA geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of VEGFA protein] |
CTD |
PMID:22213190 PMID:25051504 PMID:26364502 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
increases expression |
EXP |
2-Acetylaminofluorene results in increased expression of WEE1 mRNA |
CTD |
PMID:22584684 |
|
NCBI chr 1:174,765,228...174,790,882
Ensembl chr 1:174,767,960...174,786,361
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
decreases expression |
ISO |
2-Acetylaminofluorene results in decreased expression of WWOX mRNA |
CTD |
PMID:21607683 |
|
NCBI chr19:46,761,353...47,695,247
|
|
G |
Xdh |
xanthine dehydrogenase |
increases activity multiple interactions |
EXP |
2-Acetylaminofluorene results in increased activity of XDH protein Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of XDH protein] |
CTD |
PMID:23665045 |
|
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
G |
Xpc |
XPC complex subunit, DNA damage recognition and repair factor |
decreases response to substance |
ISO |
XPC protein results in decreased susceptibility to 2-Acetylaminofluorene |
CTD |
PMID:23153559 |
|
NCBI chr 4:123,134,457...123,161,985
Ensembl chr 4:123,134,457...123,161,985
|
|
G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of ZEB1 protein |
CTD |
PMID:19167416 |
|
NCBI chr17:54,656,627...54,714,920
Ensembl chr17:54,658,463...54,714,914
|
|
G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
decreases expression |
EXP |
2-Acetylaminofluorene results in decreased expression of ZEB2 protein |
CTD |
PMID:19167416 |
|
NCBI chr 3:29,857,289...29,985,932
Ensembl chr 3:29,862,473...29,996,865
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
multiple interactions increases expression |
ISO EXP |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of ZMAT3 mRNA] 2-Acetylaminofluorene results in increased expression of ZMAT3 mRNA |
CTD |
PMID:17070881 PMID:17317680 PMID:19167416 PMID:21607683 PMID:22584684 |
|
NCBI chr 2:118,715,229...118,746,109
Ensembl chr 2:118,721,334...118,745,766
|
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
[Acetoxyacetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TP53 protein |
CTD |
PMID:10741303 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
increases expression |
EXP |
Hydroxyacetylaminofluorene results in increased expression of ABCB1B mRNA; Hydroxyacetylaminofluorene results in increased expression of ABCB1B protein |
CTD |
PMID:22084566 |
|
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Nat1 |
N-acetyltransferase 1 |
decreases activity |
ISO |
Hydroxyacetylaminofluorene results in decreased activity of NAT1 protein |
CTD |
PMID:19842618 |
|
NCBI chr16:23,970,742...23,991,573
Ensembl chr16:23,970,743...23,991,573
|
|
G |
Nat2 |
N-acetyltransferase 2 |
decreases activity |
ISO |
Hydroxyacetylaminofluorene results in decreased activity of NAT2 protein |
CTD |
PMID:19842618 |
|
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases sulfation |
ISO |
SULT2A1 protein results in increased sulfation of Hydroxyacetylaminofluorene |
CTD |
PMID:10752640 |
|
NCBI chr 1:76,558,721...76,614,315
Ensembl chr 1:76,252,329...76,780,230
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
EXP |
Hydroxyacetylaminofluorene results in increased expression of TP53 protein |
CTD |
PMID:9163691 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|